4.1300
-0.4900
(-10.61%)
At close: April 10 at 4:00:02 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| HUHN STEPHEN L Officer | Conversion of Exercise of derivative security | Aug 13, 2024 | 12,800 |
| LORRAIN DANIEL S. PH.D. Officer | Sale | Nov 25, 2024 | 172,460 |
| VERSANT VENTURE CAPITAL VI, L.P. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Apr 9, 2024 | -- |
Related Tickers
AARD Aardvark Therapeutics, Inc. Common Stock
7.02
-9.88%
SEPN Septerna, Inc.
5.16
-8.02%
MBX MBX Biosciences, Inc.
6.27
-2.03%
UPB Upstream Bio, Inc.
6.40
-1.99%
BCAX Bicara Therapeutics Inc.
10.15
-2.40%
BOLD Boundless Bio, Inc.
1.1900
-0.83%
SION Sionna Therapeutics, Inc.
7.66
-13.74%
SYRE Spyre Therapeutics, Inc.
11.93
-10.77%
MAZE Maze Therapeutics, Inc.
7.60
-4.64%
XNCR Xencor, Inc.
7.92
-10.10%